1-(1H-indol-4-yloxy)-3-[(2R,4S)-2-methyl-4-(6-methyl-1-benzothiophen-2-yl)piperidin-1-yl]propan-2-ol
C26H30N2O2S — CID 142071984
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(1H-indol-4-yloxy)-3-[(2R,4S)-2-methyl-4-(6-methyl-1-benzothiophen-2-yl)piperidin-1-yl]propan-2-ol
1-(1H-indol-4-yloxy)-3-[(2R,4S)-2-methyl-4-(6-methyl-1-benzothiophen-2-yl)piperidin-1-yl]propan-2-ol (PubChem CID 142071984) has the molecular formula C26H30N2O2S and a molecular weight of 434.61 g/mol. Its IUPAC name is 1-(1H-indol-4-yloxy)-3-[(2R,4S)-2-methyl-4-(6-methyl-1-benzothiophen-2-yl)piperidin-1-yl]propan-2-ol.
Molecular Properties
| Compound Name | 1-(1H-indol-4-yloxy)-3-[(2R,4S)-2-methyl-4-(6-methyl-1-benzothiophen-2-yl)piperidin-1-yl]propan-2-ol |
|---|---|
| PubChem CID | 142071984 |
| Molecular Formula | C26H30N2O2S |
| Molecular Weight | 434.61 g/mol |
| Exact Mass | 434.20 |
| IUPAC Name | 1-(1H-indol-4-yloxy)-3-[(2R,4S)-2-methyl-4-(6-methyl-1-benzothiophen-2-yl)piperidin-1-yl]propan-2-ol |
| SMILES | Cc1ccc2cc([C@H]3CCN(CC(O)COc4cccc5[nH]ccc45)[C@H](C)C3)sc2c1 |
| InChI | InChI=1S/C26H30N2O2S/c1-17-6-7-19-14-26(31-25(19)12-17)20-9-11-28(18(2)13-20)15-21(29)16-30-24-5-3-4-23-22(24)8-10-27-23/h3-8,10,12,14,18,20-21,27,29H,9,11,13,15-16H2,1-2H3/t18-,20+,21?/m1/s1 |
| InChIKey | OCNYAGTUKGAQCN-LGWYJFNUSA-N |
| XLogP | 5.70 |
| TPSA | 48.49 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 434.61 |
| LogP ≤ 5 | 5.70 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142071984 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.